Drug intelligence / Profile preview

CASi-005

Development stage
Preclinical
Lead developer
Switch Therapeutics
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

CASi-005 is a preclinical-stage small interfering RNA (siRNA) therapeutic being developed by Switch Therapeutics. It utilizes the company's proprietary Conditionally Activated siRNA (CASi) platform, which is designed for targeted delivery and activation, specifically optimized for central nervous system (CNS) applications. The CASi platform aims to provide long-lasting gene knockdown with improved safety and potency compared to traditional RNAi approaches. While the specific biological target and primary indication remain undisclosed, the program is part of a pipeline focused on addressing significant unmet needs in neurological disorders.

Beyond the preview

Go deeper on CASi-005.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CASi-005.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call